(Q34532228)

2 August 2017

Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors (English)

1 reference

2 August 2017

0 references

0 references

1 reference

1 reference

Amy K Dickason-Chesterfield

1

1 reference

2 August 2017

Stephanie R Kidd

2

1 reference

2 August 2017

Steven A Moore

3

1 reference

2 August 2017

John M Schaus

4

1 reference

2 August 2017

Bin Liu

5

1 reference

2 August 2017

George G Nomikos

6

1 reference

2 August 2017

Christian C Felder

7

1 reference

2 August 2017

31 May 2006

1 reference

Cellular and Molecular Neurobiology

2 August 2017

1 reference

2 August 2017

26

1 reference

2 August 2017

4-6

1 reference

2 August 2017

407-423

1 reference

https://scigraph.springernature.com/pub.10.1007/s10571-006-9072-6

2 August 2017

0 references

cites work

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10571-006-9072-6

Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties

21 January 2018

1 reference

12 December 2020

Accumulation of anandamide: evidence for cellular diversity

1 reference

12 December 2020

Evidence for novel cannabinoid receptors

1 reference

12 December 2020

Endogenous cannabinoid signaling

1 reference

12 December 2020

Signal transduction activated by cannabinoid receptors.

1 reference

12 December 2020

Anandamide transport: a critical review.

1 reference

12 December 2020

1 reference

12 December 2020

Rimonabant Sanofi-Synthélabo.

1 reference

12 December 2020

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

1 reference

12 December 2020

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

12 December 2020

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

1 reference

12 December 2020

Rimonabant--a selective CB1 antagonist

1 reference

12 December 2020

Novel selective and metabolically stable inhibitors of anandamide cellular uptake

1 reference

12 December 2020

Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells.

1 reference

12 December 2020

Cannabinoid physiology and pharmacology: 30 years of progress.

1 reference

12 December 2020

Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.

1 reference

12 December 2020

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

12 December 2020

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

12 December 2020

Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase

1 reference

12 December 2020

Molecular characterization of human and mouse fatty acid amide hydrolases

1 reference

12 December 2020

Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle

1 reference

12 December 2020

Delta-9-Tetrahydrocannabinol: Localization in Body Fat

1 reference

12 December 2020

Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D

1 reference

12 December 2020

Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate

1 reference

12 December 2020

Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling

1 reference

12 December 2020

Cannabinoid signalling

1 reference

12 December 2020

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

12 December 2020

In silico patent searching reveals a new cannabinoid receptor

1 reference

12 December 2020

The endocannabinoid signaling system: pharmacological and therapeutic aspects

1 reference

12 December 2020

The endocannabinoid system and its therapeutic exploitation

1 reference

12 December 2020

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

1 reference

12 December 2020

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

1 reference

12 December 2020

Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase

1 reference

12 December 2020

Identification of a high-affinity binding site involved in the transport of endocannabinoids

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter

1 reference

12 December 2020

A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase

1 reference

12 December 2020

Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide

1 reference

12 December 2020

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

12 December 2020

Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization

1 reference

12 December 2020

Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

10.1007/S10571-006-9072-6

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference